As regards IHN, Finland has submitted to the Commission information demonstrating that the conditions for the approval of disease-free status from IHN, laid down in Delegated Regulation (EU) 2020/689, are fulfilled for the remaining compartment in Finland that is not yet recognised as disease-free. Following the assessment by the Commission, that application has been shown to comply with the criteria laid down in Part II, Chapter 4, of Delegated Regulation (EU) 2020/689 for the granting of disease-free status from IHN. Therefore, the whole territory of Finland should be listed in Part I of Annex XIII to Implementing Regulation (EU) 2021/620, as having disease-free status from IHN. That Annex should, therefore, be amended accordingly.
Recital 11, Regulation (EU) 2026/293
In forcesince 9 Feb 2026